Haemostatic Failure of Prothrombin Complex Concentrates during Elective Dental Procedure

Summary

One haemophilia A patient with an inhibitor was exposed to a graded surgical procedure and treated with Prothrombin Complex Concentrates (PCC). Hemostasis was not obtained until the inhibitor was neutralized and the patient�s factor VIII level was normal. This patient is presented to emphasize that PCC are not nearly as effective as once hoped in producing hemostasis in inhibitor patients. Consequently, major decisions should not be made presuming efficacy of these products in inhibitor patients.

• References

• 1 Andrews P. 1970; Methods in biochemical analysis. 18: 53
• 2 David Glick. Interscience Publishers; New York, London:
• 3 Astrup T, Mullertz G. 1952; Fibrin plate method for estimating fibrinolytic activity. Archives Biochemistry 40: 346
• 4 Brown ME. 1960; Esterase Activity. Journal Laboratory Clinical Medicine 55: 516
• 5 Cawley LP, Eberhard L. 1962; Simplified gel electrophoresis. I. Rapid technique applicable to the clinical laboratory. American Journal Clinical Pathology 38: 539
• 6 Colman RW. 1969; Activation of Plasminogen by human plasma kallikrein. Biochemical Biophysical Research Communications. 35: 273
• 7 Davis BJ. 1964; Disc electrophoresis. II. Method and application to human serum proteins. Annals of the New York Academy of Science 121: 404
• 8 Diaz A, Corral JF, Henriques Olga B. 1978; Estudio at liberaci�n “espontánea” de Quininas en fracciones parcialmente purificadas de quininogeno I y II del plasma humano. Actualizaciones en Hematologia 3: 79
• 9 Henriques OG, Allan L. 1972; Glass activates kallikrein from human plasma. Biochemical Pharmacology 21: 3163
• 10 Kaplan AP, Austen KF. 1972; The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. Journal Experimental Medicine 136: 1378
• 11 Laake K, Vennerod AM. 1974; Factor XII induced fibrinolysis: Studies on the separation of prekallikrein, plasminogen proactivator and factor XI in human plasma. Thrombosis Research 4: 285
• 12 Lowry CH, Rosebrough NJ, Farr AL, Randal RJ. 1951; Protein measurement with the folin phenol reagent. Journal Biological Chemistry 193: 265
• 13 Ogston D, Ogston MC, Ratnoff OD. 1969; Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: The participation of Hageman factor and additional cofactors. Journal Clinical Investigation. 48: 1786
• 14 Ogston D, Bennett B, Mackie M. 1976; Properties of a partially purified preparation of a circulating plasminogen activator. Thrombosis Research. 8: 275
• 15 Ratnoff OD, Davie EW. 1962; The purification of activated Hageman Factor (Activated factor XII). Biochemistry 1: 967
• 16 Spackman DH, Stein WH, Moore S. 1958; Automatic recording apparatus for use in the chromatography of amino acids. Annals Chemistry 30: 1190
• 17 Spragg J, Kaplan Allen P, Austen KFrank. 1973; The use of iseolectric focusing to study components of the human plasma kinin-forming system. Annals of the New York Academy of Sciences 209: 372
• 18 Vennerod AM, Laake K. 1974; Isolation and characterization of prealbumen activator of prekallikrein from acetone activated human plasma. Thrombosis Research. 4: 103
• 19 Vennerod AM, Laake K. 1976; Prekallikrein and plasminogen activator absence of plasminogen proactivator in Fletcher factor deficient palsma. Thrombosis Research. 8: 519
• 20 Weber K, Osborn M. 1969; The reliability of molecular weight determination by Dodesyl sulphate polyacrylamide gel electrophoresis. The Journal of Biological Chemistry. 244: 4406